New York City, NY – According to filings with the U.S. Securities and Exchange Commission, Spine BioPharma is raising $5,000,515.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Marc Viscogliosi played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Spine BioPharma

Patients around the world are struggling with debilitating back pain, trying to avoid invasive surgeries and the potential of opioid addiction. Spine Biopharma has developed a non-surgical solution that will remove pain and restore functionality, without having to use opioids.

To learn more about Spine BioPharma, visit http://www.spinebiopharma.com/

Contact:
Marc Viscogliosi, Chief Executive Officer
212-583-9700
https://www.linkedin.com/in/marc-viscogliosi-750ba6b/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved